Acute Heart Failure 2018: Global Epidemiology, Patient Flow, Prevalence and Diagnosed & Treated Patient Analysis - Forecast to 2026 - ResearchAndMarkets.com

DUBLIN--()--The "Global Acute Heart Failure Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

This research provides insights into Acute Heart Failure epidemiology, Acute Heart Failure diagnosed patients, and Acute Heart Failure treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Acute Heart Failure derived from epidemiological analysis, patients diagnosed with Acute Heart Failure, and patients treated with a drug therapy.

The research study helps executives estimate Acute Heart Failure market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Acute Heart Failure prevalence, Acute Heart Failure diagnosis rate, and Acute Heart Failure treatment rate for the period 2017-2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Features

  • Acute Heart Failure Patient Flow
  • Acute Heart Failure Prevalence
  • Acute Heart Failure Diagnosed Patients
  • Acute Heart Failure Treated Patients

Key Topics Covered

1. Acute Heart Failure: Disease Definition

2. Global Acute Heart Failure Patient Flow

2A. Global Acute Heart Failure Prevalence

2B. Global Acute Heart Failure Diagnosed Patients

2C. Global Acute Heart Failure Treated Patients

3. Acute Heart Failure Patient Flow in the US

3A. Acute Heart Failure Prevalence in the US

3B. Acute Heart Failure Diagnosed Patients in the US

3C. Acute Heart Failure Treated Patients in the US

4. Acute Heart Failure Patient Flow in Europe

4A. Acute Heart Failure Prevalence in Europe

4B. Acute Heart Failure Diagnosed Patients in Europe

4C. Acute Heart Failure Treated Patients in Europe

5. Acute Heart Failure Patient Flow in Germany

5A. Acute Heart Failure Prevalence in Germany

5B. Acute Heart Failure Diagnosed Patients in Germany

5C. Acute Heart Failure Treated Patients in Germany

6. Acute Heart Failure Patient Flow in France

6A. Acute Heart Failure Prevalence in France

6B. Acute Heart Failure Diagnosed Patients in France

6C. Acute Heart Failure Treated Patients in France

7. Acute Heart Failure Patient Flow in Spain

7A. Acute Heart Failure Prevalence in Spain

7B. Acute Heart Failure Diagnosed Patients in Spain

7C. Acute Heart Failure Treated Patients in Spain

8. Acute Heart Failure Patient Flow in Italy

8A. Acute Heart Failure Prevalence in Italy

8B. Acute Heart Failure Diagnosed Patients in Italy

8C. Acute Heart Failure Treated Patients in Italy

9. Acute Heart Failure Patient Flow in UK

9A. Acute Heart Failure Prevalence in UK

9B. Acute Heart Failure Diagnosed Patients in UK

9C. Acute Heart Failure Treated Patients in UK

10. Acute Heart Failure Patient Flow in Japan

10A. Acute Heart Failure Prevalence in Japan

10B. Acute Heart Failure Diagnosed Patients in Japan

10C. Acute Heart Failure Treated Patients in Japan

11. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/hd6422/acute_heart?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Drugs